Molecular networks in Network Medicine: Development and applications is a research paper published in WIREs Systems Biology and Medicine (2020). On theSindex it has a DataRank of 0.812. It has been cited 223 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.812
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →European Cooperation in Science and Technology
Grant: CA15120
Horizon 2020 Framework Programme
Grant: 737586
Proof of principle for a first in class neuroprotective therapy in stroke and other acute neurodegenerative conditions
Horizon 2020 Framework Programme
Grant: 777111
An in silico-based approach to improve the efficacy and precision of drug REPurpOsing TRIALs for a mechanism-based patient cohort with predominant cerebro-cardiovascular phenotypes
Horizon 2020 Framework Programme
Grant: 826078
Privacy preserving federated machine learning and blockchaining for reduced cyber risks in a world of distributed healthcare
Horizon 2020 Framework Programme
Grant: 826121
individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology
National Institutes of Health
Grant: 1R35CA220523
National Institutes of Health
Grant: K25HL133599
National Institutes of Health
Grant: P01HL105339
National Institutes of Health
Grant: P01HL114501
National Institutes of Health
Grant: P50GM107618
National Institutes of Health
Grant: R01HL111759
National Institutes of Health
Grant: R01HL133135
National Institutes of Health
Grant: R01HL137927
National Institutes of Health
Grant: R01HL147148
National Institutes of Health
Grant: U01HG007690
National Institutes of Health
Grant: U01HL089856
National Institutes of Health
Grant: U54HL1191145
NCI NIH HHS
Grant: R35 CA220523
NHLBI NIH HHS
Grant: U54 HL119145
National Institutes of Health
Grant: 5P01HL114501-02
Distinct and Overlapping Pathways of Fibrosis and Emphysema in Cigarette Smokers
National Institutes of Health
Grant: 5R01HL133135-03
COPD Susceptibility, Heterogeneity, and Progression: Proteomics and Genetics
National Institutes of Health
Grant: 5R01HL137927-02
Identifying functional variants in COPD GWAS loci
National Institutes of Health
Grant: 5P50GM107618-02
The HMS Laboratory of Systems Pharmacology
National Institutes of Health
Grant: 5K25HL133599-04
Using Integrative Networks to Explore Heterogeneous Phenotypes in COPD
National Institutes of Health
Grant: 1U01HL089856-01A1
Genetic Epidemiology of COPD
National Institutes of Health
Grant: 1U01HG007690-01
Center for Integrated Approaches to Undiagnosed Diseases
National Institutes of Health
Grant: 1R35CA220523-01A1
Unraveling the Complexities of Risk and Mechanism in Cancer
European Commission
Grant: 841281
Controllability of biological networks
National Institutes of Health
Grant: 1R01HL147148-01
Genetic and Functional Dissection of a Cluster of COPD GWAS Signals on Chromosome 4q
National Institutes of Health
Grant: 3R01HL111759-02S1
Using Networks to Assign Gene Function in Lung Disease
Ministero dell'Istruzione dell'Università e della Ricerca
Grant: 20152TE5PK
Epitargeting of Acute Myeloid Leukemia: a Synergistic Multidisciplinary Approach
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 3 of SAveRUNNER: an R-based tool for drug repurposing
Additional file 3 of SAveRUNNER: an R-based tool for drug repurposing
Additional file 4 of SAveRUNNER: an R-based tool for drug repurposing
Additional file 4 of SAveRUNNER: an R-based tool for drug repurposing
Additional file 1 of Gauging innovation and health impact from biomedical research: survey results and interviews with recipients of EU-funding in the fields of Alzheimer’s disease, breast cancer and prostate cancer
Additional file 1 of Gauging innovation and health impact from biomedical research: survey results and interviews with recipients of EU-funding in the fields of Alzheimer’s disease, breast cancer and prostate cancer
Additional file 2 of Gauging innovation and health impact from biomedical research: survey results and interviews with recipients of EU-funding in the fields of Alzheimer’s disease, breast cancer and prostate cancer
Additional file 2 of Gauging innovation and health impact from biomedical research: survey results and interviews with recipients of EU-funding in the fields of Alzheimer’s disease, breast cancer and prostate cancer
Additional file 1 of The potential DNA methylation markers of cardiovascular disease in patients with type 2 diabetes
Additional file 1 of The potential DNA methylation markers of cardiovascular disease in patients with type 2 diabetes
Additional file 2 of The potential DNA methylation markers of cardiovascular disease in patients with type 2 diabetes
Additional file 2 of The potential DNA methylation markers of cardiovascular disease in patients with type 2 diabetes